analyse_media
The image is from UPSC CMS 2025 Paper I and contains the following question (shown upside down on screen):
Q. 115. Which one of the following oral drugs may be used in the management of super-refractory status epilepticus?
- (a) Clonazepam
- (b) Clobazam
- (c) Lamotrigine
- (d) Topiramate ✅
Note on the answer shown: The image shows "Answer: (d) I and IV" which appears to be a misprint or belongs to a different question format. For this specific question, (d) Topiramate is the correct answer.
Why Topiramate?
In super-refractory status epilepticus (SRSE) - defined as status epilepticus that continues or recurs 24 hours or more after the onset of anaesthetic therapy - Topiramate is one of the oral/enteral agents used as an add-on therapy. It can be administered via nasogastric tube and has multiple mechanisms of action (sodium channel blockade, AMPA/kainate receptor antagonism, carbonic anhydrase inhibition).
Among the options:
- Clonazepam and Clobazam are benzodiazepines - useful in early/established SE, not specifically indicated in SRSE management protocols
- Lamotrigine has no established role in acute SE management
- Topiramate is specifically listed in SRSE treatment algorithms as an enteral option
The note also mentions this is a repeat question from Prasad Comprehensive Guide, 12th edition (65% repeat rate), marked in red.
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Here is the full question from the image (UPSC CMS 2025 Paper I, Q.118) and a detailed analysis of each statement:
Q. 118. Which of the following statements are correct regarding the management of gastrointestinal bleeding in children?
- I. Somatostatin or octreotide infusion should be given for at least 7 days after stoppage of initial bleeding to prevent rebleeding
- II. Endoscopic Sclerotherapy (EST) involves endoscopic injection of N-butyl-2-cyanoacrylate or isobutyl-2-cyanoacrylate
- III. EST has upto 90% efficacy in controlling acute bleeding
- IV. Following an episode of acute variceal bleeding, all patients should receive secondary prophylaxis to prevent rebleeding
Select the answer using the code given below:
- (a) I and II
- (b) I and III
- (c) III and IV
- (d) II and IV
Statement-by-Statement Analysis
Statement I - INCORRECT
Somatostatin/octreotide is given for up to 5 days (not 7 days) after initial bleeding control. The standard regimen is:
- Octreotide: 50 mcg IV bolus, then 50 mcg/hr infusion for up to 5 days
This is confirmed by multiple textbooks (Sleisenger & Fordtran; Yamada's Gastroenterology): "The dose of octreotide for acute variceal hemorrhage is a 50 μg bolus followed by a continuous IV infusion of 50 μg/hr for up to 5 days." - Sleisenger & Fordtran's GI and Liver Disease
Statement II - CORRECT
Endoscopic Sclerotherapy (EST/endoscopic sclerotherapy) does involve injection of N-butyl-2-cyanoacrylate (BCA) or isobutyl-2-cyanoacrylate - these tissue adhesives (glues) are the standard agents used. Yamada's Gastroenterology confirms: "The commonly used synthetic glues, n-butyl-2 cyanoacrylate (BCA) and 2-octyl cyanoacrylate (OCA), are liquid monomers that polymerize on contact with blood, solidifying within the varix instantly."
Statement III - CORRECT (with nuance)
Cyanoacrylate injection (endoscopic) achieves initial control of bleeding in >90% of patients. Yamada's confirms: "Cyanoacrylate injection is the preferred endoscopic treatment option for fundal variceal hemorrhage, with initial control of bleeding in more than 90% of patients and rebleeding rates <15%."
However, sclerotherapy (EST) with sclerosants (like ethanolamine, sodium tetradecyl sulfate) is different from cyanoacrylate injection - and the question groups them. For standard EST of esophageal varices, hemostasis rates are approximately 80-90%.
Statement IV - CORRECT
After an acute variceal bleed, all patients should receive secondary prophylaxis (combination of non-selective beta-blockers + endoscopic variceal ligation, or cyanoacrylate injection for gastric varices) to prevent rebleeding. This is a universal recommendation in all guidelines.
Answer: (c) III and IV
Statements III and IV are correct. Statement I is incorrect (5 days, not 7). Statement II is partially debatable - cyanoacrylate glue is more accurately "endoscopic obturation/glue injection" rather than "sclerotherapy," but if the question uses EST broadly, II could also be considered correct.
Note on the answer key: If the official answer is (d) II and IV, then the examiner is treating Statement II (cyanoacrylate injection as part of EST) as correct and Statement III as incorrect (perhaps distinguishing EST from glue injection for the 90% figure). Given the UPSC CMS context, the most likely intended answer is (c) III and IV, as III and IV are unambiguously correct from standard gastroenterology texts.
- Yamada's Textbook of Gastroenterology, 7th ed. - Cyanoacrylate injection section
- Sleisenger & Fordtran's GI and Liver Disease - Medical Management of Acute Variceal Bleeding
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
The question is clear from the image. I'll answer this comprehensively from core knowledge of pediatric airway management.
UPSC CMS 2025 Paper I - Q. 119
Which of the following are advantages of endotracheal intubation, in a child requiring pediatric advanced life support?
- I. Inspiratory time can be controlled
- II. Positive end-expiratory pressure can be provided
- III. Peak expiratory pressure can be controlled
- IV. Reduced risk of aspiration of gastric contents
Options:
- (a) I, II and III
- (b) I, II and IV
- (c) I, III and IV
- (d) II, III and IV
Statement-by-Statement Analysis
Statement I - CORRECT: Inspiratory time can be controlled
With an endotracheal tube (ETT) and mechanical ventilation, the clinician has full control over the I:E ratio and inspiratory time. This is a definitive advantage over bag-mask ventilation where inspiratory time is less precisely controlled.
Statement II - CORRECT: Positive end-expiratory pressure (PEEP) can be provided
PEEP requires a closed, sealed airway circuit - this is only possible with a cuffed ETT (or tight-fitting mask with CPAP). Endotracheal intubation allows precise, sustained PEEP delivery to improve oxygenation and prevent alveolar collapse.
Statement III - CORRECT: Peak expiratory pressure can be controlled
With ETT and mechanical ventilation, both inspiratory and expiratory pressures (including PEEP and peak pressures) are fully controllable. In conditions like air trapping or bronchospasm, expiratory flow can be managed.
Statement IV - CORRECT: Reduced risk of aspiration of gastric contents
This is one of the primary advantages of endotracheal intubation. A cuffed ETT physically seals the trachea from the esophagus, preventing passive regurgitation and aspiration of gastric contents during resuscitation - a key reason intubation is preferred over bag-mask ventilation in prolonged resuscitation.
Answer: (d) II, III and IV
Wait - let me re-examine. All four statements appear correct. The key question is whether "peak expiratory pressure" is a legitimate advantage that distinguishes ETT from other airway methods, or if it is a distractor.
Actually, Statement III ("peak expiratory pressure can be controlled") is somewhat misleading - "peak expiratory pressure" is not a standard ventilator parameter. The standard parameters are:
- PIP (peak inspiratory pressure) - controlled with ETT ✓
- PEEP (positive end-expiratory pressure) - controlled with ETT ✓
- Inspiratory time - controlled ✓
"Peak expiratory pressure" is not a routinely set parameter - it is a consequence of expiratory flow dynamics, not directly controlled. This makes Statement III potentially incorrect or a distractor.
Correct Answer: (b) I, II and IV
Statements I, II, and IV are the well-established, textbook advantages of endotracheal intubation:
| Statement | Verdict | Reason |
|---|---|---|
| I. Inspiratory time controlled | ✅ Correct | Full ventilator control |
| II. PEEP can be provided | ✅ Correct | Requires sealed airway - ETT provides this |
| III. Peak expiratory pressure controlled | ❌ Not standard | "Peak expiratory pressure" is not a set parameter; PIP (inspiratory) is |
| IV. Reduced aspiration risk | ✅ Correct | Cuffed ETT seals trachea |
The correct answer is (b) I, II and IV.
The note confirms this is a repeat from Prasad Comprehensive Guide, 12th edition (65% repeat rate), marked in red.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
UPSC CMS 2025 Paper I - Q. 120 (Repeat from UPSC 2018, Paper I, Q.28)
Which of the following are causes of hypocalcemia in a child?
- I. Hypomagnesemia
- II. Hypophosphatemia
- III. Metabolic acidosis
- IV. Pseudohypoparathyroidism
Options:
- (a) I and II
- (b) II and III
- (c) III and IV
- (d) I and IV
Statement-by-Statement Analysis
Statement I - CORRECT: Hypomagnesemia CAUSES hypocalcemia
This is a well-established mechanism. Harrison's (22nd ed.) explicitly states: "There are at least two causes of the hypocalcemia in severe hypomagnesemia - impaired PTH secretion and reduced responsiveness to PTH."
Severe hypomagnesemia:
- Suppresses PTH secretion from parathyroid glands
- Causes end-organ resistance to PTH at bone and kidney
Result: functional hypoparathyroidism → hypocalcemia. This is why hypomagnesemia must be corrected first when treating refractory hypocalcemia.
Statement II - INCORRECT: Hypophosphatemia does NOT cause hypocalcemia
It is the opposite - hyperphosphatemia causes hypocalcemia (phosphate chelates free calcium). Hypophosphatemia actually occurs in hyperparathyroidism (PTH reduces renal phosphate reabsorption) and is associated with normal or high calcium. Schwartz's Surgery confirms: acute hypocalcemia can occur with hyperphosphatemia because phosphorus complexes with calcium.
Statement III - INCORRECT: Metabolic acidosis does NOT cause hypocalcemia
Metabolic acidosis actually INCREASES ionized calcium by displacing calcium from albumin binding. In acidosis, H⁺ ions compete with Ca²⁺ for albumin binding sites, releasing more free ionized calcium. Conversely, metabolic alkalosis decreases ionized calcium (causes hypocalcemic symptoms like tetany).
Statement IV - CORRECT: Pseudohypoparathyroidism CAUSES hypocalcemia
Pseudohypoparathyroidism (PHP) is a group of disorders characterized by:
- Hypocalcemia + hyperphosphatemia
- Elevated PTH levels (the gland produces PTH normally)
- End-organ (kidney/bone) resistance to PTH action
The National Kidney Foundation Primer confirms: "Pseudohypoparathyroidism describes a group of disorders characterized by hypocalcemia and hypophosphatemia, elevated PTH levels, and lack of tissue responsiveness to PTH."
Answer: (d) I and IV
| Statement | Verdict | Mechanism |
|---|---|---|
| I. Hypomagnesemia | ✅ CAUSE | Impairs PTH secretion + end-organ PTH resistance |
| II. Hypophosphatemia | ❌ NOT a cause | Hyperphosphatemia causes hypocalcemia (not hypo) |
| III. Metabolic acidosis | ❌ NOT a cause | Acidosis increases ionized Ca²⁺; alkalosis decreases it |
| IV. Pseudohypoparathyroidism | ✅ CAUSE | PTH resistance → hypocalcemia + hyperphosphatemia |
Correct answer: (d) I and IV
- Harrison's Principles of Internal Medicine, 22nd ed. - Acquired and Hereditary Hypoparathyroidism
- Costanzo Physiology, 7th ed. - Regulation of PTH Secretion
This is a shared conversation. Sign in to Orris to start your own chat.